HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Northland Securities lowered their FY2026 EPS estimates for shares of HIVE Blockchain Technologies in a note issued to investors on Tuesday, February 17th. Northland Securities analyst M. Grondahl now forecasts that the company will post earnings per share of ($0.76) for the year, down from their previous forecast of ($0.42). Northland Securities also issued estimates for HIVE Blockchain Technologies’ Q4 2026 earnings at ($0.30) EPS, Q1 2027 earnings at ($0.30) EPS, Q2 2027 earnings at ($0.29) EPS, Q3 2027 earnings at ($0.27) EPS, Q4 2027 earnings at ($0.20) EPS and FY2027 earnings at ($1.05) EPS.
A number of other research firms also recently weighed in on HIV. B. Riley Financial upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a report on Friday, November 21st. Keefe, Bruyette & Woods lowered HIVE Blockchain Technologies from a “moderate buy” rating to a “hold” rating in a research report on Tuesday, January 27th. Two investment analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Buy”.
HIVE Blockchain Technologies Price Performance
HIVE Blockchain Technologies Ltd. is a business services company in the Business Services industry.
Read More
- Five stocks we like better than HIVE Blockchain Technologies
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- How a Family Trust May Be Able To Help Preserve Your Wealth
- This makes me furious
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
